KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Payables (2016 - 2025)

Evolent Health has reported Payables over the past 11 years, most recently at $59.8 million for Q4 2025.

  • Quarterly results put Payables at $59.8 million for Q4 2025, down 77.65% from a year ago — trailing twelve months through Dec 2025 was $59.8 million (down 77.65% YoY), and the annual figure for FY2025 was $59.8 million, down 77.65%.
  • Payables for Q4 2025 was $59.8 million at Evolent Health, down from $77.3 million in the prior quarter.
  • Over the last five years, Payables for EVH hit a ceiling of $267.5 million in Q4 2024 and a floor of $37.8 million in Q3 2021.
  • Median Payables over the past 5 years was $62.9 million (2022), compared with a mean of $90.2 million.
  • Peak annual rise in Payables hit 518.96% in 2025, while the deepest fall reached 77.65% in 2025.
  • Evolent Health's Payables stood at $96.1 million in 2021, then plummeted by 40.5% to $57.2 million in 2022, then fell by 15.62% to $48.2 million in 2023, then surged by 454.43% to $267.5 million in 2024, then tumbled by 77.65% to $59.8 million in 2025.
  • The last three reported values for Payables were $59.8 million (Q4 2025), $77.3 million (Q3 2025), and $241.6 million (Q2 2025) per Business Quant data.